Trials / Completed
CompletedNCT06825754
The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Shao Yuekai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
By measuring the expression levels of MicroRNA-21-5p (miR-21-5p) and LncRNAgadd7 in the peripheral blood of ARDS patients, the study aims to explore the correlation between these levels and the severity and prognosis of ARDS.
Conditions
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-11-30
- Completion
- 2025-01-10
- First posted
- 2025-02-13
- Last updated
- 2025-02-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06825754. Inclusion in this directory is not an endorsement.